Atıf Formatları
Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

T. Cirpan Et Al. , "Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2, pp.177-178, 2006

Cirpan, T. Et Al. 2006. Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2 , 177-178.

Cirpan, T., Akercan, F., Itil, I., Gundem, G., Bilgen, I., & Yucebilgin, M., (2006). Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2, 177-178.

Cirpan, TEKSİN Et Al. "Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2, 177-178, 2006

Cirpan, TEKSİN Et Al. "Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2, pp.177-178, 2006

Cirpan, T. Et Al. (2006) . "Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.27, no.2, pp.177-178.

@article{article, author={TEKSİN ÇIRPAN Et Al. }, title={Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?}, journal={EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY}, year=2006, pages={177-178} }